The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of RIP2 and/or mutants thereof, for use in the diagnosis, prevention and/or treatment of RIP2-kinase associated diseases. Moreover, the present invention provides methods of using said compounds, for instance as a medicine or diagnostic agent.本發明係關於巨環化合物及含有該等化合物之組成物,其充當激酶抑制劑,尤其RIP2及/或其突變體之抑制劑,用於診斷、預防及/或治療RIP2激酶相關疾病。此外,本發明提供使用該等化合物例如作為醫藥或診斷劑之方法。